Affimed Presents Preclinical Data of Novel Innate Cell Engager AFM28 at the Annual Meeting of the European Hematology Association (EHA)
AFM28 induced potent, effective, and specific anti-tumor activity against CD123-positive cells irrespective of mutational status…
The Great AI Divide: Why Infrastructure Maturity Determines Who Scales and Who Stalls
SPARC AI Enhances Overwatch with AI Telemetry Optimization to Reduce Drift and Improve Mission Reliability
GA-ASI Achieves New Milestone With Semi-Autonomous CCA Flight